Literature DB >> 12687509

A prospective study of sicca symptoms in patients with rheumatoid arthritis.

Johan G Brun1, Tor Magne Madland, Roland Jonsson.   

Abstract

OBJECTIVE: To investigate sicca symptoms in patients with rheumatoid arthritis (RA) with respect to constancy, temporal changes of prevalence, and possible risk factors.
METHODS: A prospective cohort study of 70 patients with RA was conducted over 5 years. The main variables of interest were the 6 questions on sicca symptoms used in the preliminary European criteria for Sjögren's syndrome.
RESULTS: Fourteen patients were lost to followup. We found that 84.2% (95% confidence interval [95% CI] 59.5-95.8) of the patients reporting sicca symptoms at baseline also reported them at followup. During the study period, sicca symptoms increased by 52.6% in general (P = 0.02) and by 80.0% for the ocular components (P = 0.04). Sicca symptoms (odds ratio [OR] = 8.35, 95% CI 1.91-36.49) and pain (OR = 1.03, 95% CI 1.00-1.07) at baseline were identified as independent predictive factors for sicca symptoms at followup.
CONCLUSIONS: Sicca symptoms in patients with RA are remarkably constant over time. There is also a substantial time-dependent increase in the prevalence of such symptoms. As the prevalence of ocular sicca symptoms in general populations tend to level out with age, there seems to be a disease-related increase of ocular symptoms over time in patients with RA. Present pain and sicca symptoms constitute risk factors for future sicca symptoms.

Entities:  

Mesh:

Year:  2003        PMID: 12687509     DOI: 10.1002/art.10999

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review.

Authors:  Divi Cornec; Alain Saraux; Sandrine Jousse-Joulin; Jacques-Olivier Pers; Sylvie Boisramé-Gastrin; Yves Renaudineau; Yves Gauvin; Anne-Marie Roguedas-Contios; Steeve Genestet; Myriam Chastaing; Béatrice Cochener; Valérie Devauchelle-Pensec
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 2.  Ocular inflammatory diseases associated with rheumatoid arthritis.

Authors:  Mathieu Artifoni; Pierre-Raphaël Rothschild; Antoine Brézin; Loïc Guillevin; Xavier Puéchal
Journal:  Nat Rev Rheumatol       Date:  2013-12-10       Impact factor: 20.543

Review 3.  Diagnosis and treatment of xerostomia (dry mouth).

Authors:  Joel J Napeñas; Michael T Brennan; Philip C Fox
Journal:  Odontology       Date:  2009-07-29       Impact factor: 2.634

4.  Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients.

Authors:  Ketil Moen; Johan G Brun; Tor Magne Madland; Turid Tynning; Roland Jonsson
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

5.  Serum, urinary, and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures.

Authors:  J Brice Weinberg; Thomas Lang; William E Wilkinson; David S Pisetsky; E William St Clair
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

6.  Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye.

Authors:  Susan Vitale; Linda A Goodman; George F Reed; Janine A Smith
Journal:  Health Qual Life Outcomes       Date:  2004-09-01       Impact factor: 3.186

7.  Use of the dexamethasone-corticotrophin releasing hormone test to assess hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis.

Authors:  Eman A Hasan; David S Jessop; Lynsey L Power; Paul T Monk; John R Kirwan
Journal:  Int J Endocrinol       Date:  2009-09-29       Impact factor: 3.257

8.  Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases.

Authors:  Pilar Uribe-Reina; Juliana Muñoz-Ortiz; Carlos Cifuentes-González; Juliana Reyes-Guanes; Juan Pablo Terreros-Dorado; William Zambrano-Romero; Carolina López-Rojas; Fabien Mantilla-Sylvain; Rubén Darío Mantilla-Hernández; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2021-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.